Through partnering with leading organisations, we seek to maximise the potential of exosome therapeutics, either by solving delivery and development challenges for partners using our proprietary DeliverEXTM platform or to accelerate the development of our in-house rare disease assets with the aid of outside expertise and capabilities.
Partnering discussions fall into two areas:
Platform partnering opportunities
Evox seeks partners for our DeliverEXTM platform who have promising drug targets that are difficult to reach with conventional means or have drug candidates or products that could be improved through exosome engineering.
- Engineering of exosome therapeutics to enable the delivery of various drug cargoes, for instance, protein biologics, antibodies, AAV, RNA therapeutics (siRNA, ASO, mRNA) or gene editing modalities
- Targeted exosome-mediated drug delivery
Pipeline partnering opportunities
We have a relentless commitment to progressing our rare disease programs to impact patients' lives and we are always on the lookout for partners who can help us achieve this aim.
For business development opportunities, please reach out here.